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INTRODUCTION
Nonvariceal upper gastrointestinal (UGI) bleeding is 
defined as bleeding originating at the level of the distal 
esophagus, stomach, and the duodenum (proximal to the 
ligament of Treitz). Nonvariceal UGI bleeding results in the 
hospitalization of 30-100 patients per 100000 population 
per year, which is two-to-four times more common than 
lower GI bleeding (1).
The most common causes of UGI bleeding are peptic 
ulcer disease, benign and malignant tumors, gastritis, 
arteriovenous malformations (such as Dieulafoy lesions), 
Mallory-Weiss tears, pancreatitis, and iatrogenic causes (2). 
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Endoscopy is the primary invasive technique for the 
diagnosis and treatment of UGI bleeding. When medical 
and endoscopic treatments fail, surgery or interventional 
embolotherapy are the treatment options. After the first 
report of selective arterial embolization of gastroepiploic 
artery for the control of acute gastric bleeding (3), 
improvements in interventional devices and embolic 
materials and wider availability of skilled interventional 
radiologists have increased the utility of embolization 
procedures in the management of UGI bleeding. 
Indications/Contraindications
The typical candidate patient presents with the following: 
1) massive bleeding (transfusion requirement of at least 4 U 
blood over 24 hours) or hemodynamic compromise (systolic 
blood pressure < 100 mm Hg and heart rate > 100 beats per 
minute or clinical shock), 2) endoscopy-refractory acute UGI 
bleeding, 3) recurrent bleeding after surgery. In general, 
the more hemodynamically unstable a patient is, the greater 
the chance of identifying the source of bleeding. 
There are no absolute contraindications because 
angiography and embolization may be needed as lifesaving 
procedures. For patients with severe reactions to iodinated 
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contrast media, alternative contrast agents such as carbon 
dioxide can be used. Relative contraindications include 
renal insufficiency, contrast allergy, and uncorrectable 
coagulopathy. There is increased risk of gastric or 
duodenal infarction after embolotherapy in patients with 
previous extensive UGI surgery or radiotherapy. If the 
rate of bleeding is massive, surgery may be preferable to 
angiography, since angiography may not be able to control 
the bleeding as quickly as surgery (4).
Procedure
Diagnostic Angiography
Screen-film arteriography can demonstrate bleeding at 
rates as low as 0.5 mL/min in a canine model (5), but in 
vitro studies suggest that digital subtraction arteriography 
is five to nine times more sensitive than screen-film 
arteriography in detecting hemorrhage (6), which seems 
to be equivalent to detection rates of scintigraphic images 
(7). The major limitation of angiography relates to the 
intermittent nature of bleeding, which can result in a 
negative study if the bleeding has temporarily stopped at 
the time of contrast injection. 
Glucagon and Buscopan may be given before the 
procedure to decrease bowel motility and motion artifacts 
during digital subtraction angiography (8). Aortograms 
are usually not performed, since visualization of contrast 
extravasation into the GI tract requires more selective 
injection (4). The vessel selected first should be based on 
the suspicion of the likely source of bleeding according to 
history, clinical signs, as well as localization provided by 
scintigraphic images or computed tomography scans. For 
UGI bleeding, the celiac and superior mesenteric arteries 
(SMAs) are the primary targets. If there is no sign of active 
bleeding on injection of the main trunks, more selective 
injection may be needed. For duodenal or gastric fundus 
bleeding, the gastroduodenal artery (GDA), or left gastric 
arteries, respectively, should be studied (4). Obtaining 
images should be continued until the venous phase has 
cleared out to help distinguish contrast extravasation from 
persistent venous opacification. 
The only direct angiographic sign of UGI bleeding is 
extravasation of contrast medium into the bowel lumen (2). 
Indirect signs include aneurysms/pseudoaneurysms, vessel 
irregularity, vessel cutoff and arteriovenous/arterioportal 
shunting, neovascularity, and increased vascularity 
from dilated arterioles (as seen in angiodysplasia). It is 
important to image into the venous phase. 
When a bleeding source is not identified because GI 
bleeding is often intermittent, provocative angiography may 
improve the rate of positive angiographic findings. Infusion 
of tolazoline (vasodilators), heparin, or even thrombolytics 
like tissue plasminogen activator, stimulate bleeding to 
allow the pathology to be localized. In one study based 
on 16 patients with nonlocalized lower GI bleeding from 
previous endoscopic and angiographic studies, these 
infusions identified the bleeding site in 37.5% of cases 
without causing any hemodynamic instability (9).
Embolization
The choice of embolic agent depends on a combination of 
the vascular anatomy, angiographic findings, the achievable 
catheter position, and the operator preference (Table 1). 
The most common embolic agents are metallic coils and 
Table 1. Commonly Used Embolic Materials for Embolotherapy of Gastrointestinal Bleeding
Duration Materials Mechanism Advantages Disadvantages
Gelatin  
  sponge
Temporary
Purified pork 
  skin gelatin
Mechanical occlusion,  
  structural support  
  to the thrombus
Inexpensive, readily 
  available
Recanalizes within 
  a few weeks, 
  unpredictable delivery
PVA
Relatively 
  permanent
By grinding 
  large PVA blocks
Mechanical occlusion,  
  structural support  
  to the thrombus
Wide variety of sizes, 
  easy to use
Microcatheter clumping
Coil Permanent
Stainless steel 
  or platinum
Mechanical occlusion,  
  platelet activation,  
  clotting cascade
Wide variety of sizes, 
  easy to use, radiopacity
Requires intact 
  coagulopathy
NBCA Permanent NBCA Polymerization  
  with blood
Rapid embolization, 
  useful for coagulopathy
Difficult to control
Note.— PVA = polyvinyl alcohol, NBCA = N-butyl-cyanoacrylate
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polyvinyl alcohol (PVA) particles (usually 300-500 μm). 
Use of coils as the only embolic agent is significantly 
associated with early rebleeding, compared with the use of 
PVA or gelatin sponge with coils (10, 11). Use of N-butyl 
cyanoacrylate (NBCA) is advantageous for massive bleeding 
that requires urgent hemostasis, especially in patients with 
coagulopathy because of rapid embolization (12). 
Types of embolization can be classified into localized, 
proximal, and segmental embolizations (Fig. 1). Localized 
embolization is possible when the bleeding point is 
superselected. Proximal embolization is defined when 
a microcatheter could not enter the bleeding point and 
embolization is done in its parent artery, while the bleeding 
point and its distal part are not embolized. Segmental 
embolization is when an adjacent branch artery or arteries 
are included to be embolized. With proximal embolization, 
recanalization of the bleeding point can occur due to distal 
back flow. With excessive segmental embolization, ischemic 
complications of the involved bowel can occur. 
One of the useful maneuvers in localizing culprit vessels 
requires clips to be placed around the area of bleeding 
during pre-embolization endoscopy. The clips remain in 
position for several hours and allow for an educated guess 
of the location of the culprit vascular branch (13, 14). If 
no extravasation is seen despite the injection of contrast, 
then the branches terminating at the clip are superselected 
using microcatheter techniques and embolized. Rotational 
angiography can be useful to determine the relationship 
between the metallic clip and a culprit vessel (14). 
Vasopressin infusion works by constricting the mesenteric 
vessels and contraction of the smooth muscle in the bowel 
wall, thus reducing the blood flow to the site of bleeding 
and inducing the formation of a stable clot at the bleeding 
site. Patients should be on continuous cardiac monitoring, 
since vasopressin can induce coronary vasoconstriction. 
Infusion is started at 0.1 units/min. Repeat angiography 
is performed after 20 minutes to ensure that bleeding has 
stopped and that the vessels are not overconstricted. If 
bleeding persists, the dose is increased to 0.2 units/min. 
Infusion is then increased to 0.4 units/min if bleeding 
persists. Excessive vasoconstriction can lead to bowel 
infarction. It is known to be effective in patients with 
microcatheter-inaccessible bleeding or diffuse bleeding 
(such as hemorrhagic gastritis). However, disadvantages 
include the rate of rebleeding after discontinuation of the 
infusion, cardiovascular complications, and the difficulty in 
maintaining a selective catheter position. In one study, the 
success rate of 52% for vasopressin was inferior than that 
of 88% for embolization in major GI bleeding (15). 
The GDA has a dual supply from both the hepatic artery 
and SMA. Back pressure may allow continued bleeding 
if embolization is performed proximally. A microcatheter 
is advanced beyond the bleeding site and embolization 
is done to prevent backflow to the bleeding site. Then, 
the microcatheter is withdrawn, depositing more embolic 
agent, until the embolization takes place proximal to the 
bleeding site, using the so-called sandwich technique. 
Likewise, bleeding from the pancreaticoduodenal arcade 
should be treated by embolizing the arteries both proximal 
and distal to the lesion. GI bleeding from GDA stump is 
quite common after pancreaticobiliary surgery (Fig. 2). 
Embolization both proximal and distal to the GDA stump 
or stent-graft placement could be an option. Although 
hepatic ischemia or infarction develops in 30-40% of 
patients with embolization of both proximal and distal to 
the GDA stump (Fig. 2), patent portal vein and extensive 
collateral pathways, including the inferior phrenic arteries 
and gastric arteries, usually serve to protect the liver from 
ischemic insult (16). Stent-graft placement is better than 
Fig. 1. Three patterns of embolization according to 
embolization level for non-terminal (A) and terminal (B) 
arteries. 
In localized embolization (1), superselective embolization is done for 
bleeding point without embolizing other adjacent arteries. In proximal 
embolization (2), e.g. microcatheter-inaccessible bleeding point, only 
the artery proximal to the bleeding point is embolized. In segmental 
embolization (3), not only bleeding point but also adjacent branch 
artery or arteries are embolized together.
A B
(1) (1)
(2) (2)
(3) (3)
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embolization for preserving intrahepatic arterial flow. Post-
embolization ‘check’ angiograms from both the celiac axis 
and SMA sides are required to ensure that no collateral 
supply to the bleeding site is present. 
Embolization of pseudoaneurysms needs to be mentioned. 
Packing the sac of the pseudoaneurysm with coils should be 
avoided because this rebleeding is almost inevitable (16, 
17). Because the wall of the pseudoaneurysm is weak, the 
breakdown or rupture of the weaker pseudoaneurysm (than 
normal adjacent arterial wall) seems to occur after only sac 
packing with embolic materials. Therefore, the sandwich 
technique of both proximal and distal to the bleeding 
site should be done. In those cases with microcatheter-
inaccessible bleeding point, particulate or liquid embolic 
agents should be utilized. In cases requiring deeper 
penetration, liquid embolic materials such as NBCA could be 
an option (Fig. 3). 
Fig. 2. 63-year-old woman with pylorus-preserving pancreaticoduodenectomy for ampulla of Vater cancer. 
A. Celiac angiogram shows intraluminal bleeding (arrows) from gastroduodenal artery (GDA) stump to jejunal loops. B. Celiac angiogram 
immediately after microcoil embolization shows complete embolization of both proximal and distal portions of GDA stump. Note minimal 
collateral (arrowhead) from left gastric artery. C. Axial contrast-enhanced computed tomography scan one day after embolization shows multifocal 
hepatic infarctions (asterisks) in liver. D. Computed tomography follow-up one month after embolization shows complete disappearance of 
hepatic infarctions. 
A
C
B
D
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Outcome
Six recent representative studies of embolization for 
nonvariceal UGI bleeding in 299 patients showed technical 
success rates of 92-100% and clinical success rates of 51-
94% (11, 18-22). Rebleeding rates were 9-47%, rates 
for surgery were 0-35%, and 30-day mortality rates were 
3-27%. A wide range of clinical success and rebleeding 
A B
Fig. 3. 54-year-old man with ERCP-induced pancreatitis. 
This patient had undergone embolization for bleedings from short gastric and left interior phrenic arteries. A. Superior mesenteric artery (SMA) 
angiogram shows pseudoaneurysm (arrow) at distal gastroduodenal artery. B. The tip (arrowhead) of microcatheter was advanced as far as to 
pseudoaneurysm (arrow), however, could not reach it. C. N-butyl cyanocrylate (NBCA) embolization (1 : 3 mixture with lipiodol) was done with 
NBCA cast covering pseudoaneurysm. D. Completion SMA angiogram shows no visualization of pseudoaneurysm. Hematochezia was controlled.
C D
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rates, rates for surgery, as well as 30-day mortality rates 
seem to have originated from different etiologies and 
clinical severities. 
Major factors associated with rebleeding include 
coagulopathy, longer time to angiography, massive 
transfusion, previous surgery, multi-organ system failure, 
bleeding secondary to trauma, invasive procedures, cancer 
bleeding (rather than non-cancer bleeding), or use of coils 
as the only embolic agent (11, 21-24). In one study (25), 
18 of 32 patients (56%) had a diagnosis of a coagulopathy 
A B
Fig. 4. 65-year-old man with B-cell lymphoma presented with melena. 
A. Celiac angiogram shows contrast extravasation (arrows) from small branches of gastroduodenal artery. B, C. Long segmental embolization was 
done with N-butyl cyanocrylate (NBCA) to prevent back flow from the superior mesenteric artery. Spot radiograph (B) and superior mesenteric 
artery angiogram (C) show NBCA cast (arrowheads) without further bleeding. D. A computed tomography scan 4 days later showed bowel 
ischemia and perforation (arrows) with peritonitis surrounding radiopaque embolic material (arrowheads). 
C D
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prior to arrival to the angiographic suite; the angiographic 
success rate in this group of patients was 100% and the 
clinical success rate was 83% in spite of their coagulopathy. 
For patients with coagulopathy, NBCA could be an excellent 
option because NBCA does not depend on the coagulation 
process (22, 25). In another study (22), coagulopathy was 
observed in 41% (29/71 patients), and the clinical success 
rate with and without coagulopathy was not significantly 
different. 
Because of the intermittent nature of many incidents of 
UGI bleeding, the incidence of a normal angiogram in a 
patient with acute upper and lower GI bleeding was 52% 
(75 out of 143 patients) in one recent report (26). In the 
latter study, the incidence of an angiographically negative 
outcome was significantly higher in patients with a stable 
hemodynamic status, or in patients with lower GI bleeding. 
During follow-up, most patients (80%, 60/75) with a 
negative bleeding focus experienced spontaneous resolution 
of their condition without rebleeding. When no evidence 
of bleeding is found on angiography, blind or prophylactic 
embolization (usually with gelatin sponge and/or coils), 
defined as embolization without angiographic proof of 
extravasation, could be an alternative and is typically 
guided by endoscopic information regarding the location of 
the bleeding vessel (2, 10, 27, 28). Although a high rate of 
clinical success cannot be expected with such prophylactic 
embolization because of possible intermittent nature of 
the GI bleeding, especially in gastric cancer patients, a 
significant proportion of such patients will benefit (10, 27, 
28).
Patients with angiographic extravasation show a marked 
decrease in mortality when embolization is successful, 
compared with patients requiring surgery after failed 
embolization (38 vs. 83%) (29). Overall, survival is strongly 
correlated with clinical failure. In one study, patients with 
a successful embolization had one-sixth of the mortality 
rate of those with a failed embolization regardless of their 
clinical condition (11%, 10 of 95 vs. 68%, 44 of 68) (24). 
Coagulopathy, rescue surgery after a failed attempt for 
embolization, underlying medical problems such as cirrhosis 
and malignancy, and multisystem organ failure are related 
with poor survival (2, 10, 24). 
Complications and Their Managements
Access site hematoma and pseudoaneurysms, arterial 
dissection, contrast allergic reactions, and nephrotoxicity 
can occur with the same frequency as in other endovascular 
procedures. 
Arterial embolization in the UGI tract above the ligament 
of Treitz is generally considered very safe because of the 
rich collateral supply to the stomach and duodenum. 
However, the risk of significant ischemia or stricture could 
be increased when potential collateral vessels are damaged 
from previous upper abdominal surgery, radiotherapy, or 
severe atherosclerosis, or when liquid agents such as NBCA, 
or very small particles advance far into the vascular bed 
(22, 23, 30) (Fig. 4). Lang (31) reported a 16% (9/57 
patients) incidence rate of duodenal strictures following 
embolization. If true bowel infarction occurs, surgical 
resection is generally required. For more chronic ischemic 
complications such as bowel stricture, balloon dilation may 
be possible, but surgical resection should be considered if 
the stricture is resistant to balloon dilation. 
Nontarget embolization involves embolic material 
inadvertently passing into a vascular bed that was not the 
intended target. This may result from excessive pressure 
when injecting flow-directed particles or from buckling of 
the delivery catheter out of the target vessel during coil 
deployment. Removal can be attempted for the embolic 
materials blocking a critical vessel. Suction with a catheter 
can be used for some particulate emboli, but errant coils 
need to be retrieved with snares. 
CONCLUSION
Nonvariceal UGI bleeding remains an often serious 
clinical challenge. A multidisciplinary approach of 
endoscopists, surgeons, and interventional radiologists is 
important. With improvements in catheter-based therapy 
and endovascular device development, angiography and 
embolization procedures is considered the gold standard 
for acute nonvariceal UGI bleeding refractory to endoscopy. 
Interventional radiologists should also be familiar to several 
clinical and technical factors which affect the clinical 
outcome of embolotherapy in certain settings. 
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